Janssen Search
Search results
ASCO/EHA 2022
Welcome to the Janssen Oncology ASCO Virtual Newsroom Peter Lebowitz, M.D., Ph.D. Global Therapeutic Area Head Oncology Janssen Research & Development, LLC Tyrone Brewer U.S. President Oncology Janssen Biotech, Inc. Strength in Numbers: How Data ...
Championing Patient-Centric, Data-Driven Clinical Trials
Championing Patient-Centric, Data-Driven Clinical Trials The Question that Drives Clinical Trial Innovation One common question I receive as Janssen Clinical Innovation’s Global Team Lead is, “what will clinical trials look like in five years, 10 ...
Diversity Leads to Breakthroughs
Dec 12, 2019 Janssen believes diverse backgrounds & thinking drive innovation & success Article Block Text: <p>Your unique view can make a difference. We believe diverse backgrounds and thinking drive innovation and success.</p> ...
The 2016 MedTech Boston 40 Under 40 Healthcare Innovators
The 2016 MedTech Boston 40 Under 40 Healthcare Innovators Jan 06, 2017 Article Block Text: MedTech Boston – May 2, 2016 Redirect URL: https://medtechboston.medstro.com/blog/2016/05/02/the-2016-medtech-boston-40-under-40-healthcare-innovators ...
Partners in Cardiovascular & Metabolism
Partner with Janssen in Cardiovascular & Metabolism Our one team philosophy guides us and our partners toward a shared vision: eliminating cardiovascular and metabolic diseases so all people can lead happier, healthier, longer lives. Seeking the Best ...
Our Team: Leading the Fight Against Cancer
Our Team: Leading the Fight Against Cancer At Janssen Oncology, we share a deep passion for scientific innovation and for bringing together the best expertise worldwide to make promising treatments available to patients who are waiting for them. Our ...
Paul Anthony
Paul Anthony Human Resources Head Global Pharmaceuticals and External Innovation Paul Anthony is Human Resources (HR) Head of Global Pharmaceuticals & External Innovation at Johnson & Johnson. Paul serves as a member of Johnson & Johnson’s ...
HIV Treatment and Prevention
Innovations in HIV Treatment and Prevention HIV absorption. Janssen is exploring innovative applications of our HIV medicines to improve treatment and prevention outcomes in hard-to-reach areas by finding ways to reduce the frequency of dosing. We’re also ...
TransCelerate Biopharma
Janssen Participates in TransCelerate Biopharma to Accelerate Development of New Medicines Janssen and nine other leading biopharmaceutical companies formed TransCelerate BioPharma Inc. (TransCelerate), a non-profit organization dedicated to improving the ...
Value of Medicines
How We Think About Value, Access and Pricing We advance healthy outcomes by ensuring healthcare professionals and patients have access to the information, programs and support they need to achieve the best results possible. At Janssen, we seek medical ...